Cargando…
Can management of the components of metabolic syndrome modify the course of chronic kidney disease?
Autores principales: | Kim, Yaeni, Park, Cheol Whee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Nephrology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321678/ https://www.ncbi.nlm.nih.gov/pubmed/32522892 http://dx.doi.org/10.23876/j.krcp.20.066 |
Ejemplares similares
-
Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2019) -
Niacin in patients with chronic kidney disease: Is it effective and safe?
por: Park, Cheol Whee
Publicado: (2013) -
New therapeutic agents in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2017) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Response to comment on “New therapeutic agents in diabetic nephropathy”
por: Kim, Yaeni, et al.
Publicado: (2017)